Elysium Pharmaceuticals Ltd, a active public limited company, was established on 11 January 1995 in Vadodara, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ1995PLC024164. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹22.00 Cr and a paid-up capital of ₹16.00 Cr.
It upholds a compliant status. Employing 337 professional, Its leadership includes Vithalbhai Shankerbhai Patel (Director), Hiren Prakash Barot (Additional Director), Jinkal Darshan Patel (Whole-Time Director). Past directors included Ashokkumar Vallavbhai Patel, Vithalbhai Shankerbhai Patel, Mukund Laxman Abhyankar. It holds ₹81.05 Cr open charges and ₹165.22 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.1175, P.O. Dabhasa, Tal. Padra, Vadodara, Gujarat, 391440.
U24231GJ1995PLC024164
024164
11 January 1995
₹22.00 Cr
₹16.00 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Elysium Pharmaceuticals Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vithalbhai Shankerbhai Patel | Director | 21 Jun 2006 | Current |
| Hiren Prakash Barot | Additional Director | 17 Feb 2025 | Current |
| Jinkal Darshan Patel | Whole-Time Director | 30 Jan 2020 | Current |
| Chandani Ankitkumar Jhanwar | Director | 17 Feb 2023 | Current |
| Shitalkumar Navnitbhai Patel | Whole-Time Director | 30 Jan 2020 | Current |
| Yashwantrai Chunibhai Patel | Managing Director | 25 Sep 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2013 | Past |
| Pramod Abcsdd | Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 01 Apr 2013 | Past |
| Pramod Abcsdd | Director | 01 Oct 2021 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Elysium Pharmaceuticals Ltd, for the financial year ended 2021, experienced significant growth in revenue, with a 93.92% increase. The company also saw a substantial improvement in profitability, with a 208.42% increase in profit. The company's net worth Soared by an impressive increase of 49.63%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Elysium Pharmaceuticals had a promoter holding of 90.37% and a public holding of 9.63%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹810,500,000.00
₹1,652,190,851.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Mar 2022 | Others | ₹18.43 Cr | Open |
| 04 Jul 2014 | Others | ₹31.31 Cr | Open |
| 11 Dec 2010 | Others | ₹31.31 Cr | Open |
| 15 Mar 2022 | Others | ₹2.29 Cr | Satisfied |
| 27 Oct 2021 | Others | ₹26.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Elysium Pharmaceuticals has a workforce of 337 employees as of Mar 03, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Elysium Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elysium Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 31 Aug 2021 via Charge ID 100483450 with Others was fully satisfied on 07 Aug 2025. was documented.
The activity A charge with Others of Rs. 31.31 Cr registered on 04 Jul 2014 with Charge ID 10508871 was modified on 07 Aug 2025. was completed.
Progress on A charge registered on 15 Feb 2014 via Charge ID 10480281 with State Bank Of India was fully satisfied on 07 Aug 2025. was documented.
Progress on A charge with Others of Rs. 31.31 Cr registered on 11 Dec 2010 with Charge ID 10257659 was modified on 07 Aug 2025. was documented.
Progress on A charge registered on 16 Feb 2010 via Charge ID 10209989 with State Bank Of India was fully satisfied on 07 Aug 2025. was documented.
Progress on A charge registered on 03 Jul 2002 via Charge ID 80047401 with State Bank Of India was fully satisfied on 07 Aug 2025. was documented.
The CIN of Elysium Pharmaceuticals Ltd is U24231GJ1995PLC024164.
Elysium Pharmaceuticals Ltd is headquartered at Plot No.1175, P.O. Dabhasa, Tal. Padra, Vadodara, Gujarat, 391440.
Elysium Pharmaceuticals Ltd was incorporated on 11 January 1995.
The current directors of Elysium Pharmaceuticals Ltd are
The primary industry of Elysium Pharmaceuticals Ltd is Manufacturing.
Elysium Pharmaceuticals Ltd is unlisted.
The authorized capital of Elysium Pharmaceuticals Ltd is ₹22.00 Cr, and the paid-up capital is ₹16.00 Cr.
The compliance status of Elysium Pharmaceuticals Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX